BOSTON–AcuityMD, a Boston-based artificial intelligence platform serving the medical technology industry, has been ranked No. 57 on Deloitte’s 2026 Technology Fast 500 list of the fastest-growing technology companies in North America.
The company reported revenue growth of 1,306% between 2022 and 2025, placing it among the top performers in the annual ranking, which is now in its 32nd year.
AcuityMD provides an AI-powered platform designed to help medical device companies analyze healthcare markets, identify commercial opportunities and improve decision-making.
The company attributed its rapid growth to increasing adoption of artificial intelligence among medical technology companies seeking to improve commercial operations and identify opportunities for expanding the use of medical devices.
Mike Monovoukas, Co-Founder and CEO of AcuityMD, said the company’s growth reflects a broader shift in how medical technology companies use data and AI to guide business decisions.
“We’re honored to be recognized by Deloitte, and grateful to the customers who got us here,” said Monovoukas. “When we started AcuityMD, we saw a chance to fundamentally change how MedTech teams find the right opportunities and make better decisions. Our mission has always been to accelerate the adoption of medical technology, and AI is helping our customers do that even faster. As we continue to invest in AcuityAI, we’re excited to see what they’ll do next.”
The company’s AcuityAI technology is part of its broader platform designed to help commercial teams understand healthcare delivery patterns and identify potential markets for medical technologies.
The Deloitte Technology Fast 500 recognizes companies across North America based on percentage revenue growth over a three-year period.
Companies included in the 2026 rankings recorded revenue growth ranging from 97% to 66,330%, with an average growth rate of 1,134%.
Justin Yahr, Audit & Assurance Partner and National Emerging Growth Company Leader at Deloitte & Touche LLP, said the rankings reflect continued expansion among established technology companies and emerging businesses.
“The 2026 rankings demonstrate that established momentum and breakthrough growth can drive sustained market leadership,” said Yahr. “Nearly 70% of this year’s award winners returned as repeat honorees, reflecting the power of disciplined and sustained execution. More than 30% made the list for the first time, illustrating how quickly new players are shaping their respective sectors. Furthermore, private companies represented almost 80% of the list, a clear indication that the agility and strategic focus of private enterprises remain essential to scaling in competitive markets.”
AcuityMD’s inclusion among the top 60 companies highlights the growing role of artificial intelligence and data analytics in the medical technology industry’s commercial operations.
The company continues to invest in its AI capabilities as medical device manufacturers increasingly adopt digital platforms to support market analysis, sales strategies and technology adoption.


